Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Recruiting · NCT06883097 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Quitting Matters Human Immunodeficiency Virus Hybrid Trial | AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, nicotine dependence, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-09-30 | NCT06883097 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
| University at Buffalo | 14 |
| Wake Forest University Health Sciences | 284 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wake Forest University, Implementation Science | Winston-Salem | United States | 1 |